Abstract Library

#2015 Single-Institutional Review of Non-Pancreatic GI Neuroendocrine Tumors

Introduction: Neuroendocrine tumors (NETs) most commonly occur in the digestive tract with an incidence of 3.56 per 100,000 with 94% of those being non pancreatic.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: el chami a

Authors: El Chami A, El Halabi I, Charaffedine M, Temraz S, Mukherji D,

Keywords: neuroendocrine tumor, gastrointestinal, location, prognosis,

#1376 Pancreatic Neuroendocrine Tumors: Experience of a Tertiary Care Center

Introduction: Pancreatic neuroendocrine tumors (PNET) are rare functionally and biologically heterogeneous tumors accounting for less than 5% of pancreatic cancer

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Assi R

Authors: Assi R, Hakim A, Mukherji D, Abdel-Massih S, Charafeddine M,

Keywords: PNET stage IV surgery ki67,

#1292 The Role of 68Ga- DOTA-NOC PET in Evaluating Neuroendocrine Tumors: Real-World Experience from Single Lebanese Institution.

Introduction: Functional imaging with somatostatin analogues have been commonly used in NETs

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Assi R

Authors: Assi R, Shamseddine A, Jreige M, Mukherji D, Abou Said R,

Keywords: NET, Gallium PET,

#883 Primary Hepatic Neuroendocrine Tumors: Four Familial Case Series with Review of Literature

Introduction: Non-multiple endocrine neoplasia (MEN) familial neuroendocrine tumors (NET) are very rare with only six families being described to date. Primary hepatic neuroendocrine tumors (PHNETs) are rare tumors with a particular sporadic diagnosis. Herein, we report a series of four members of one Lebanese family, diagnosed with primary hepatic neuroendocrine tumors.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Assi R

Authors: Assi R, Haidar A, Khalife M, Temraz S, Mukherji D,

Keywords: familial primary hepatic neurendocrine tumors, genetic studies ,

#834 Nuclear Imaging in Intermediate Grade Neuroendocrine Tumors

Introduction: Early diagnosis and grading is essential to the treatment decision-making in neuroendocrine tumors. Conventionally, proliferation rate (Ki-67) level is used for the grading of NET. Ga-68 SMS-R PET/CT is the imaging method of choice for the detection of unknown primary neuroendocrine tumors. It is very sensitive in well-differentiated tumors (Ki-67 < 2%). Poorly and undifferentiated tumors having Ki-67 greater than 20% are primarily responsible for false negativity of Ga-68 SMS-R PET/CT. In those patients, FDG-PET is performed to localize the site of the primary tumor.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Abou Yehia Z, Haydar A, Haydar M, Mukherji D, Temraz S,

Keywords: neuroendocrine tumors, nuclear imaging, histopathology ,